If they offered $1 billion --- then ~$3
it's complicated though with phase III still to do
We can speculate but nothing else
The obesity market is much bigger than 10 billion by the way - that would be the size of Australia's problem
The US...well, roughly, 10s time the population and a slightly bigger problem ~$10 billion US
Consevatively say 20% of this market would be willing and able to use the drug.... still AU$1 billion seems a reasonable offer
Anyone know of recent buy-outs that would be similar?
If they offered $1 billion --- then ~$3it's complicated though...
Add to My Watchlist
What is My Watchlist?